| Year |
Citation |
Score |
| 2020 |
Monahan K, Kleman A, Thapa B, Szabo A, D'Souza A, Dhakal B, Jerkins JH, Pasquini MC, Hamadani M, Hari PN, Chhabra S. Propylene glycol (PG)-free melphalan versus PG-melphalan as conditioning for autologous hematopoietic cell transplantation for myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32920204 DOI: 10.1016/J.Bbmt.2020.08.030 |
0.3 |
|
| 2020 |
Badar T, Szabo A, Advani A, Wadleigh M, Arslan S, Khan MA, Aldoss I, Siebenaller C, Schultz E, Hefazi M, Shallis RM, Yurkiewicz I, Podoltsev N, Patel AA, Curran E, et al. Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab. Blood Advances. 4: 2308-2316. PMID 32453836 DOI: 10.1182/Bloodadvances.2019001381 |
0.325 |
|
| 2020 |
Chhabra S, Szabo A, Glisch C, George G, Narra RK, Harrington A, Jerkins JH, D'Souza A, Dhakal B, Pasquini M, Hamadani M, Hari PN. Relapse after allogeneic hematopoietic cell transplantation for multiple myeloma: Survival outcomes and factors influencing them. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32135202 DOI: 10.1016/J.Bbmt.2020.02.020 |
0.323 |
|
| 2020 |
Chhabra S, Narra RK, Wu R, Szabo A, George G, Michaelis LC, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Pasquini MC, Rizzo RD, Saber W, Shah NN, et al. Fludarabine/busulfan conditioning based allogeneic hematopoietic cell transplantation for myelofibrosis: Role of ruxolitinib in improving survival outcomes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31982543 DOI: 10.1016/J.Bbmt.2020.01.010 |
0.31 |
|
| 2020 |
Badar T, Epperla N, Szabo A, Borson S, Vaughn J, George G, Saini N, Shah AR, Patel RD, Ahmed S, Shah NN, Cashen AF, Hamadani M, Fenske TS. Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT. Blood Advances. 4: 47-54. PMID 31899797 DOI: 10.1182/Bloodadvances.2019000736 |
0.322 |
|
| 2020 |
Kleman A, Monahan K, Szabo A, D'Souza A, Dhakal B, Hamadani M, Hari P, Chhabra S. Comparison of Toxicity between Propylene Glycol (PG)-Free Melphalan with PG-Melphalan for Autologous Hematopoietic Cell Transplantation (AHCT) in Patients with Multiple Myeloma (MM) Biology of Blood and Marrow Transplantation. 26. DOI: 10.1016/J.Bbmt.2019.12.702 |
0.316 |
|
| 2019 |
Badar T, Khan MA, Szabo A, Drobyski W, Chhabra S, Dhakal B, Fenske TS, Hamadani M, Hari P, Jerkins JH, Shah NN, Shaw BE, D'Souza A. Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-6. PMID 31347424 DOI: 10.1080/13506129.2019.1645001 |
0.3 |
|
| 2019 |
Epperla N, Badar T, Szabo A, Vaughn J, Borson S, Saini NY, Patel RD, Shah NN, Hamadani M, Ahmed S, Cashen AF, Fenske TS. Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation. Blood Advances. 3: 1661-1669. PMID 31167818 DOI: 10.1182/Bloodadvances.2019000102 |
0.306 |
|
| 2019 |
Badar T, Khan MA, Szabo A, Dhakal B, Chhabra S, Fenske TS, Shah NN, Hari P, D'Souza A. Rates of Engraftment Syndrome after Autologous Stem Cell Transplantation in Patients with Immunoglobulin Light Chain Amyloidosis Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.829 |
0.308 |
|
| 2019 |
Epperla N, Badar T, Szabo A, Vaughn J, Borson S, Saini N, Patel RD, Shah NN, Hamadani M, Ahmed S, Cashen A, Fenske TS. Post-Relapse Survival in Diffuse Large B-Cell Lymphoma (DLBCL) Patients after Experiencing Therapy Failure Following Autologous Hematopoietic Cell Transplantation (auto-HCT) Biology of Blood and Marrow Transplantation. 25. DOI: 10.1016/J.Bbmt.2018.12.091 |
0.32 |
|
| 2018 |
Dhakal B, Lisa R, Szabo A, Aster RH, Padmanabhan A. Use of Intravenous Immunoglobulin G in HIT: Impact on Thrombosis and Mortality in a Population-Based Study Blood. 132: 2512-2512. DOI: 10.1182/Blood-2018-99-117190 |
0.315 |
|
| 2018 |
Murthy GSG, Szabo A, Hamadani M, Fenske TS, Shah NN. Improvements in Clinical Outcomes of Advanced Stage Classical Hodgkin Lymphoma in the United States from 2000-2014: Analysis of Surveillance Epidemiology and End Results Database Blood. 132: 2939-2939. DOI: 10.1182/Blood-2018-99-116774 |
0.322 |
|
| 2014 |
Santana-Davila R, Szabo A, Arce-Lara C, Williams CD, Kelley MJ, Whittle J. Cisplatin versus carboplatin-based regimens for the treatment of patients with metastatic lung cancer. An analysis of Veterans Health Administration data. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 702-9. PMID 24662458 DOI: 10.1097/Jto.0000000000000146 |
0.311 |
|
| Show low-probability matches. |